期刊文献+

咪达普利对高血压合并糖耐量减低患者血管内皮依赖性舒张功能的影响 被引量:3

Influence of imidapril on endothelium-dependent diastolic function in hypertension patients with impaired glucose tolerance
下载PDF
导出
摘要 目的探讨咪达普利对高血压合并糖耐量减低(impaired glucose tolerance,IGT)患者血管内皮依赖性舒张功能的影响。方法咪达普利5~10 mg/d治疗高血压合并IGT患者50例,疗程3个月,分析治疗前后血压、空腹血糖(fasting plasma glucose,FPG)、糖负荷后2 h血糖(2-hour plasma glucose,2hPG)、空腹胰岛素(fasting insulin,FINS)、胰岛素抵抗指数(HOMA-insulin resistance index,HOMA-IR)、血浆一氧化氮(NO)的变化,利用高频超声血管技术检测咪达普利治疗前后肱动脉内皮依赖性舒张(endothelium-dependent diastolic,EDD)功能,计算其舒张内径的变化率(flow mediated dila-tion,FMD)。结果与治疗前比较,治疗后患者的收缩压显著下降(P<0.01),舒张压、FINS、HOMA-IR均下降(P<0.05),血浆NO水平、FMD升高(P<0.05)。治疗前后FMD变化值(ΔD)分别与FINS、HOMA-IR、NO及其相应变化值ΔFINS、ΔHOMA-IR、ΔNO相关。结论咪达普利对高血压合并IGT患者在有效降压的同时,能明显改善内皮依赖性舒张功能。 Objective To explore the effects of imidapril on endothelium-dependent diastolic(EDD) function in hypertension patients with impaired glucose tolerance(IGT).Methods Fifty hypertension patients with IGT were treated with imidapril 5-10 mg/d for three months.Before and after treatment,blood pressure,fasting plasma glucose(FPG),2 h plasma glucose(2hPG),fasting insulin(FINS),insulin-resistance index(HOMA-IR),nitrogen monoxidum(NO) were determined.High-frequency ultrasonic imaging was used to detect the changes of brachial artery EDD function after administration with imidapril,then calculate diastolic inner diameter changing rate(FMD).Results Compared with pretherapy,the systolic blood pressure was reduced(P0.01).The diastolic blood pressure,FINS and HOMA-IR were decreased(P0.05).The plasma NO and FMD were increased(P0.05).Before treatment,FMD was correlated with FINS,HOMA-IR and plasma NO,the change of FMD before and after treatment was correlated with the change of FINS,HOMA-IR and plasma NO.Conclusion Imidapril can reduce the blood pressure,improve EDD function in hypertension patients with IGT.
作者 张春伟
出处 《现代医药卫生》 2012年第2期169-170,共2页 Journal of Modern Medicine & Health
关键词 高血压 糖耐量 咪达普利 内皮依赖性舒张功能 Hypertension Glucose tolerance Imidapril Endothelium-dependent diastolic function
  • 相关文献

参考文献8

  • 1Semenkovieh CF.Insulin resistance and atherosclerosis[J].Clin Invest, 2006, 116(7): 1813-1822.
  • 2Laplante MA, Wu R, Moreau P, et al. Endothelin mediates superoxide production in angiotensin II induced hypertension in rats [J]. Free Radic Biol Med, 2005,38(5) : 589-596.
  • 3Celemajer DS, Sorensen KE, Cooch VM,et al. Non-invasive defection of endothelial dysfunction in children and adults at risk of atherosclerosis [J]. Lancet, 1992,340(8828) : 1111-1115.
  • 4Perticone F, Maio R, Sciaequa A, et al.Endothelial dysfunetion and C -reac - tive protein are risk factors for diabetes in essential hypertension [J]. Diabetes ,2008,57(1): 167-171.
  • 5Mancia G.The association of hypertension and diabetes :prevalence ,cardiovascular risk and protection by blood pressure reduction[J]. Acta Diabetol,2005,42(Suppl 1 ) :S17-25.
  • 6Ginsberg HN. Insulin resistance and cardiovascular disease[J].J Clin Invest, 2000,106(4) :453 -458.
  • 7刘志军,刘晓方.高血压病和糖尿病的研究[J].医学综述,2004,10(11):664-665. 被引量:6
  • 8Fumta M,Tsunoda K,Arita M,et al. Endothelium dependent vaodilation in typeⅡ diabetes mellitus[J].Rinsho Byori, 2003,51(11) : 1111-1115.

二级参考文献19

  • 1董磊,姚崇华,张敏,赵冬.1979—1991年高血压患病率的变化趋势[J].心肺血管病杂志,1993,12(1):3-5. 被引量:3
  • 2The conference on the treatment of hypertension in diabetes[ J]. Diabetes Care, 1996,19[ Suppl 1] :S107-S113.
  • 3Tight hlood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 38UK Prospective Diabetes Study Group[J]. BMJ, 1998,317(7160) :703-713.
  • 4Poch E, Giner V, Nunez DG, et al. Association of the G protein β3 subunit T allete with insulin resistance in essential hypertension[ J]. Clin Exper Hypertension, 2002,24 ( 5 ) : 345 -353.
  • 5Horlkawa Y, Oda N, Cox N J, et al. Genetic variation in the gene encoding calpain 10 is associated with type 2 diabetes mellitus[ J]. Nat Gent,2000,26(2) : 163-171.
  • 6Hanson L, Zanchatti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low dose asprine in patients with hypertension:Principle results of the Hypertension Optimal Treatment (HOT) randomized trial HOT study Group [ J ].Lancet, 1998, 351 (9118) :1755-1762.
  • 7Raymond O, Estacio MD, Barter W, et al. Effect of blood pressure control on diabetetic microvascular complication in patients with hypertension and type 2 diabetes[ J ]. Diabetes Care, 2000,23 [ Suppl 2]: B54-64.
  • 81999 World Health Organization-International Society of Hypertension Guidelines for the management of Hypertension. Guidelines subcommittee[J] . J Hypertens, 1999,17(2) :151-183.
  • 9ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-eonverting enzyme inhibitor or calcium channel blocker vs diuretic :The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial(ALLHAT) [J]. JAMA, 2002,288 ( 23 ) :2981-2997.
  • 10Galletti F,Strazzullo P, Capaldo B, et al. Controlled study of the effect of angiotensin coverting enzyme inhibition versus calciumentry blockade on insulin sensitivity in overweight hypertensive patient, tranclolapril Intalian Study[ Jl .J Hypertens, 1999,17(3) :439-445.

共引文献5

同被引文献30

  • 1Celermajer D S, Sorensen K E, Gooch V M, et al.Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis[J].The Lancet, 1992, 340 ( 8828 ) : 1111-1115.
  • 2Elkayam U, Khan S, Mehboob A, et al.Impaired endothelium- mediated vasodilation in heart failure: clinical evidence and the potential for therapy[J].J Card Fail, 2002, 8 ( 1 ) : 15-20.
  • 3Rajagopalan S, Kurz S, Miinzel T, et al.Angiotensin 1I -mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation.Contribution to alterations of vasomotor tone[J].J Clin Invest, 1996, 97 ( 8 ) : 1916.
  • 4Levine B, Kalman J, Mayer L, et al.Elevated circulating levels of tumor necrosis factor in severe chronic heart failure[J].N Engl J Med, 1990, 323 (4) : 236-241.
  • 5Katz S D.Mechanisms and implications of endothelial dysfunction in congestive heart failure[J].Curr Opin Cardiol, 1997, 12 ( 3 ) : 259- 264.
  • 6Schwarz M, Katz S D, Demopoulos L, et al.Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure[J].Circulation, 1994, 89 ( 4 ) : 1609-1614.
  • 7Tomiyama H, Motobe K, Zaydun G, et al.Insulin sensitivity and endothelial function in hypertension[J].Am J Hypertens, 2005,18( 2 ): 178-182.
  • 8Wu L, Iwai M, Nakagami H, et al.Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation- induced vascular injury[J].Circulation, 2001, 104 (22) : 2716- 2721.
  • 9曾正陪.应重视从高血压人群中鉴别原发性醛固酮增多症[J].中华内科杂志,2009,48(2):95-96. 被引量:10
  • 10倪卫星,许亮,朱艳珊,包凌云,方建华,黄安茜.超声评价扩张型心肌病患者肱动脉内皮舒张功能[J].心脑血管病防治,2009,9(2):103-104. 被引量:1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部